论文部分内容阅读
目的探讨更昔洛韦对婴儿巨细胞病毒(CMV)性肝炎的疗效及副作用。方法2005年10月至2007年10月驻马店市中心医院通过检测CMV-IgG、IgM、血CMV-DNA及肝功能检测而确定82例婴儿CMV肝炎,随机分为更昔洛韦治疗组和对照组两组,均常规给予保肝治疗、退黄、补充维生素处理,更昔洛韦治疗组加用更昔洛韦。结果更昔洛韦治疗可使血CMV-DNA转阴约60%,在降低转氨酶,肝脏回缩,黄疸消退等方面与对照组比较有显著性差异(p<0.05);更昔洛韦治疗组中出现白细胞下降及血小板降低的比例分别为20%,18%。结论更昔洛韦治疗巨细胞病毒性肝炎疗效好,但要注意该药对白细胞和血小板的影响。
Objective To investigate the curative effect and side effects of ganciclovir on infant cytomegalovirus (CMV) hepatitis. Methods From October 2005 to October 2007, 82 infants with CMV hepatitis were determined by detecting CMV-IgG, IgM, CMV-DNA and liver function in Zhumadian Central Hospital. They were randomly divided into ganciclovir treatment group and control group Both groups were routinely given hepatoprotective treatment, yellow, vitamin treatment, ganciclovir plus ganciclovir treatment group. Results Ganciclovir treatment can make CMV-DNA negative about 60%, compared with the control group in reducing aminotransferase, liver shrinkage, jaundice and other aspects were significantly different (p <0.05); ganciclovir treatment group In the incidence of leukopenia and thrombocytopenia were 20%, 18%. Conclusions Ganciclovir is effective in treating cytomegalovirus hepatitis, but we should pay attention to the effect of this medicine on white blood cells and platelets.